# Castle Biosciences Inc: Form 8-K, filed Mar 27, 2024

- Company: [Castle Biosciences Inc](/companies/cstl.md) (CIK 1447362)
- Form: 8-K
- Filed: 2024-03-27
- Accepted by EDGAR: Mar 27, 2024, 17:05 ET
- Period: 2024-03-26
- Accession: 0001193125-24-078933
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1447362/000119312524078933/d782226d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447362/000119312524078933/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447362/000119312524078933/d782226d8k.htm

Filed Mar 27, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-078933. Last ingested by Listed: Nov 5, 2026, 17:16 ET. No prices; not investment advice.